USGovernment-News.Com

USGovernment-News.Com

News on U.S. government agencies, U.S. politics, companies doing business with U.S. federal government. Read U.S. national and local news. This site is not affiliated with United States Government.
Press release distribution service
Home : U.S. Government News Search Engine                          

Home > U.S. Government News > Marketplace :
Home: United State Government News
Home | News | Submit Press Release |

ClassAction.org Alerts Consumers of Reglan Black Box Warning

(EMAILWIRE.COM, February 26, 2010 ) New York, NY - ClassAction.org is alerting consumers of a black box warning for Reglan and other metoclopramide-containing drugs, which are used to treat gastrointestinal disorders. The Reglan black box warning highlights the risk of tardive dyskinesia, a disorder that causes involuntary movements of the face and extremities. The strongest FDA warning, a black box warning means the drug carries a risk of serious or life-threatening side effects.

The Reglan black box warning states that patients using metoclopramide as a long-term treatment or in high doses are at risk for the neurological disorder tardive dyskinesia. Patients with the greatest risk for this Reglan side effect are the elderly, particularly women, and those who have been taking the drug for a long period of time.

Tardive dyskinesia typically causes the following symptoms: grimacing, rapid eye blinking, lip smacking, tongue protrusion, pursing of the lips, and involuntary movements of the fingers, hands, arms, legs and shoulders. Some patients may also experience trouble breathing, swallowing, talking and walking. Unfortunately, symptoms of this Reglan side effect are rarely reversible and currently no treatment exists for tardive dyskinesia.

Reglan (generic: metoclopramide) is prescribed to treat acid reflux, diabetic gastroparesis and gastroesophageal reflux disease (GERD). Reglan works by speeding up the stomach muscles, allowing the stomach to empty more quickly into the intestines. Reglan and other metoclopramide-containing drugs are not recommended to be used longer than three months. Prescribed to more than 2 million Americans, metoclopramide-containing products include Reglan tablets, Reglan injections, Reglan oral disintegrating tablets and metoclopramide oral solution.

If you or a loved one has developed tardive dyskinesia after taking Reglan or another metoclopramide drug, visit http://www.classaction.org/reglan.html today. You may be able to participate in a lawsuit to recover financial compensation. Fill out the free, no obligation case review form to have your Reglan injury claim reviewed today.

About ClassAction.org

ClassAction.org is dedicated to protecting consumers and investors in class actions and complex litigation throughout the United States. ClassAction.org keeps consumers informed about product alerts, recalls, and emerging litigation and helps them take action against the manufacturers of defective products, drugs, and medical devices. Information about consumer fraud issues and environmental hazards is also available on the site. Visit http://www.classaction.org today for a no cost, no obligation case evaluation and information about your consumer rights.


ClassAction.org
Tara Nagel
800-449-1970
pressrelease@lawyercentral.com

Source: EmailWire.com

U.S. Governement News: Politics
  • Presidential Elections
  • Democrates
  • Congress
  • House of Representatives
  • President Obama
  • Republican Party
  • Mitt Romney
  • U.S. Senate
  • U.S. Military
  • U.S. Politics
  • Politics Video Feeds

    U.S. Government Resource Center
    We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Industry resource center today to browse our selection of 600+ complimentary Industry magazines, white papers, webinars, podcasts, and more. Get popular titles including:

    Governing
    Point of Beginning
    Overall Labor Effectiveness (OLE) Achieving a Highly Effective Workforce

    No credit cards, coupons, or promo codes required. Try it today!

    USGovernment-News.Com is a news service of GroupWeb Media LLC